Candel Therapeutics, Inc. CADL Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$54.42M-37.5% | -$38.18M+30.8% | -$22.76M+56.4% | -$22.14M+55.7% | -$39.58M-5.9% | ||
| $712K-20.0% | $808K-9.8% | $890K-1.1% | $890K-1.1% | $890K-1.1% | ||
| $4.96M+8.1% | $3.82M-28.1% | $3.77M-24.7% | $3.79M-15.9% | $4.58M+34.8% | ||
| -$47.73M-75.5% | -$38.31M-41.8% | -$33.56M-17.2% | -$29.89M+3.1% | -$27.2M+14.6% | ||
| $1.26M+10,392% | $587K+3,569% | $181K+202% | $37K-77.3% | $12K-96.3% | ||
| -$1.23M-10,167% | -$560K-3,400% | -$154K-285% | -$37K+74.1% | -$12K+96.1% | ||
| $155.15M+65.6% | $59.47M-36.9% | $107.49M+4,686% | $109.16M+19,085% | $93.67M+6,907% | ||
| $102.82M+54.7% | $17.23M-74.4% | $70.41M+366% | $79.23M+360% | $66.45M+298% | ||
| -$48.99M-80.0% | -$38.9M-43.9% | -$33.74M-17.6% | -$29.93M+3.5% | -$27.21M+15.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Candel Therapeutics, Inc. generate?
- Candel Therapeutics, Inc. (CADL) generated -$47.7M in operating cash flow over the trailing twelve months.
- What is Candel Therapeutics, Inc.'s free cash flow?
- After $1.3M of capital expenditures, Candel Therapeutics, Inc.'s free cash flow was -$49.0M over the trailing twelve months, down 80.0% year over year.
- Where does Candel Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Candel Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
